Locate Bio (“Locate”) is a cell and gene therapy company based in the UK developing breakthrough and potentially curative therapies using its next generation technologies: IntraStem™ and TAOS® are both designed to address industry recognised limitations with current cell and gene therapy approaches. IntraStem is a next generation, non viral, peptide based vector that overcomes key challenges with other viral and non-viral transfection methods, while TAOS is designed to deliver and maintain cells at the required site of action in an environment that promotes their therapeutic effects. Both technologies can be used alone or in combination for ex vivo and in vivo therapeutic applications. Locate is looking to expand its development pipeline into new therapy areas, beyond its current musculoskeletal pipeline, for in-house development and partnering.

Contact Locate Bio Limited
Visit Website